ArticlePharmaceutics2021

Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma.

Mahmoud M A Elsayed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.